With a dual-labeled imaging agent, Optical/CT/PET primary prostate cancer imaging was performed in a Siemens Inveon scanner. PET-based imaging validation shows the potential of the developed fluorescence tomography for preclinical research.
© 2012 OSA
(110.6960) Imaging systems : Tomography
(170.3010) Medical optics and biotechnology : Image reconstruction techniques
(170.6280) Medical optics and biotechnology : Spectroscopy, fluorescence and luminescence
Y. Lu, I. Tan, C. D. Darne, N. Wilganowski, H. Robinson, J. Rasmussen, S. Yan, A. M. Smith, and E. M. Sevick-Muraca, "Frequency-domain Fluorescence-enhanced Optical Tomography for Primary Prostate Cancer with PET Validation in Siemens Inveon Scanner: A Preliminary Result," in Biomedical Optics and 3-D Imaging, OSA Technical Digest (Optical Society of America, 2012), paper BTu4A.4.
References are not available for this paper.